Position in RCEL
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$12
-$325 QoQ
Shares Held
3
-95.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#72
of 73 holders
Holding Since
Sep 2025
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in RCEL Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Clearstead Advisors, LLC holds $27,209,051 across 75 Medical Devices names. RCEL ranks #73 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
149,825 | $13,595,120 | |
| 2 | SYK |
Stryker Corp
|
18,390 | $5,789,907 | |
| 3 | MDT |
Medtronic plc
|
45,296 | $3,543,506 | |
| 4 | ZBH |
Zimmer Biomet Holdings, Inc.
|
11,189 | $963,261 | |
| 5 | BSX |
Boston Scientific Corp
|
13,244 | $565,253 | |
| 6 | EW |
Edwards Lifesciences Corp
|
6,100 | $551,806 | |
| 7 | MYO |
Myomo, Inc.
|
425,609 | $442,633 | |
| 8 | GEHC |
GE HealthCare Technologies Inc.
|
6,199 | $396,797 |
All Filings in RCEL
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12 | 3 | Shares | Sole | 2026-08-06 | |
| 2025-09-30 | $337 | 66 | Shares | Sole | 2025-11-10 | |
| No filing history on record for this holder in this stock. | ||||||